Impairments of astrocyte function are probably important, especially due to their capacity to regulate the ionic and amino acid concentration in the extracellular micromilieu, brain energy metabolism, and cell volume. Recent results have shown that these functions are under monoaminergic control. Aspects of therapy are outlined.
Long term exposure to mercury may give rise to a syndrome of tremor, variable limb weakness, and ataxia due to damage of cells in the cerebellum. Also, personality changes often characterised by fatigue, stress intolerance, insomnia, irritability, and sometimes impairment of concentration capacity and of short term memory can be seen. The patients often complain of decreased simultaneous capacity and impairments in their ability to talk to several people at the same time. They also complain of increased sensitivity to sound. Similarly, exposure to low doses of lead for long periods can give rise to neurasthenic symptoms.'`5 The symptoms are important as they profoundly impair the patient's capacity to work. The nervous system is a primary target for many toxic substances but the anatomical origins of the symptoms are at present not fully understood, although neuronal networks in large parts of the cerebral cortex are believed to be affected.
Little decrease to control (ordinary) levels, leading to the previous degree of inhibition.
At higher noradrenaline concentrations (fig 5B) , a,-receptor activation results in an increased uptake of glutamate. This might be important in the state of high extracellular glutamate, which in itself mediates: (1) a high Ca2+ uptake into both neurones and glial cells with resultant low extracellular Ca2+ concentrations and thereby increased neuronal excitability73 74; (2) a glial depolarisation with increased extracellular K + that results in a decreased glial uptake of glutamate; and (3) an increase in volume with a decreased extracellular space and a further increase in the extracellular concentration of glutamate. Furthermore, a,-receptor stimulation has been shown to potentiate the fl-receptor activated glycogenolysis.5 Thus both neuronal excitability and astroglial metabolism increase, and so also does the cell volume. Hence, activation of astroglial adrenergic receptors might stimulate neurotransmission by regulation of the extracellular milieu and also the astroglial energy metabolism. The resultant decrease in pH and increase in cell volume with decreased extracellular space and increased tortuosity73 might be factors of importance in the self regulation of the stimulation.
What happens after exposure to low doses of mercury or lead? It has been shown that both mercury and lead inhibit the astroglial capacity to take up glutamate7576 ( fig 6) and even low concentrations will inhibit the activity of glutamine synthetase,7"78 the enzyme that converts glutamate to glutamine in astroglia.W If there is a slowly progressing disturbance of astroglial glutamate uptake, or glutamine synthetase activity, or both, then synaptic glutamate transmission will decrease to compensate and less glutamate will probably be released. A decreased neuronal activity mostly results in an upregulation of surface receptors79 ' and it might be that the glutamate receptors will become more sensitive. Under all circumstances cortical glutamate transmission probably decreases with a secondary decrease in transmission in other cortical neurotransmitter systems. As a regulatory consequence, the activity of the locus coeruleus will decrease to some extent and as far as can be expected from the role of cortical noradrenaline activity this might correspond to the symptoms that these patients report, namely, fatigue and lowered alertness.
The problems that appear if there is a prominent noradrenergic activation in this situation with a decreased astroglial uptake of extracellular glutamate can be pronounced. The glutamate concentration rises rapidly either in the whole cortex or locally. Cell volume probably increases and it seems that the biochemical changes correspond to the clinical situation of insufficiency, lability, and headache.
If on the other hand there is a less prominent noradrenergic activation then it is more probable that the glutamate transmission does not work effectively or distinctly due to delays in uptake from the synaptic space. This might lead to difficulties in activating many synapses in parallel. As cell volume probably increases somewhat the extracellular space decreases, which further augments the difficulties. These might be the biochemical correlates with the clinical situ- There is a decrease in glutamate uptake, more prominent in the hippocampus, even at the low mercury or lead concentrations. Similar results were obtainedfrom cultures incubated for six days at 10M of the respective metal salt with changes of the medium every day. *p < 0-05; **p < 0-01 compared to control; Student's t test. For details, see76.
ation of diminished simultaneous capacity, often reported by the patients.
Noradrenaline in very low concentrations may, on the other hand, lead to a diminished inhibition by an increased astroglial uptake of GABA mediated by stimulation of fl-receptors. This will "push the system" and prevent the glutamate receptors from being down regulated too much. Furthermore, a slight fl-receptor activation increases metabolism. In this context, it is interesting to take into account that stimulation of 5HT2 receptors on astroglial cells potentiate the f-receptor activated cyclic AMP.47
Furthermore, it was shown that 5HT, receptor activation to some extent stimulated the a,-receptor induced formation of inositol phosphate. Hypothetically, it might thus be valuable in the clinical situation to have a slight noradrenaline and a slight 5HT activation even though more specific receptor stimulation is required.
Exposure to even higher mercury or lead concentrations might severely affect astroglial uptake and give rise to a prominent increase in extracellular glutamate concentration. As high extracellular glutamate is cytotoxic8" sensitive neurones might be damaged, especially neurones in the CAI region in the hippocampus,82 resulting in memory disturbances and other permanent cognitive deficits.
Conclusions
Recent research on astroglia characteristics carried out mostly on cell culture models has shown that these cells, intimately associated and intermingled with other neuroglia and with neurones, serve important functions in regulating the extracellular microenvironment, including neuronal excitability and metabolism. The cells serve supportive and protective functions towards the neurones and they have a great capacity for regulation of volume. From this view, a behavioural model is presented that enlightens cellular and molecular mechanisms hypothetically underlying symptoms of non-focal encephalopathy such as increased fatigue, stress intolerance, and a slightly decreased cognitive capacity. The hypothesis presented is based on many lines of evidence suggesting that astroglia are targets for noradrenergic and serotoninergic activation and thereby regulate the neuronal extracellular milieu including amino acids-for example, glutamateand ions-for example, Ca2, K+, and C1 -, and Na+. Impairment of these astroglial functions, especially the high affinity glutamate uptake, by mercury or lead might lead to a less distinct glutamate transmission and a glutamate "overflow" that could result in the clinical symptoms. At higher metal concentrations the astroglial glutamate uptake is impaired even more and the extracellular glutamate might reach concentrations that are cytotoxic to neurones. Some brain regions, especially the CAl pyramidal cells in the hippocampus are especially vulnerable, probably due to their high density of N-methyl-D-aspartate receptors. Slight noradrenaline and 5HT activation may help the clinical situation. 
